Evidence for a shared HLA-A intralocus determinant defined by monoclonal antibody 131 by unknown
EVIDENCE  FOR  A  SHARED  HLA-A  INTRALOCUS 
DETERMINANT  DEFINED  BY  MONOCLONAL 
ANTIBODY  131 
BY  BRETT T.  SPEAR,  JACKI KORNBLUTH, JACK L. STROMINGER,*  ANO 
DARCY  B. WILSON 
From the Division of Research Immunology, Department of Pathology and Laboratory 
Medicine, University of Pennsylvania School of Medicine, Philadelphia,  Pennsylvania 19104; 
and the *Dana-Farber Cancer Institute,  Boston, Massachusetts 02115 
Major histocompatibility complex (MHC) t class I antigens are composed of a 
polymorphic 45 kiiodalton  (kD) glycoprotein heavy chain noncovalently associ- 
ated on the cell surface with a nonpolymorphic  12 kD protein, f32-microglobulin 
(/32-m) (1).  These  proteins  are  expressed  on  nearly  all  cells,  and  they play an 
essential  role  in  the  immune  response  of cytotoxic T  lymphocytes (CTL)  to 
foreign antigens  (reviewed in  2).  Most species express more than  one of these 
proteins. The mouse MHC, known as H-2, encodes at least three class I molecules, 
H-2K, H-2D, and  H-2L; HLA, the human  MHC, encodes at least three class I 
gene products, HLA-A, HLA-B, and HLA-C. 
One interesting aspect of MHC class I gene proteins, which may be related to 
their immune function, is their high degree of polymorphism; in the mouse, the 
H-2K and H-2D loci have at least 50 alleles (3), and the extent of polymorphism 
in  humans,  as detected serologically, seems to be of the  same  order  (4).  This 
polymorphism is localized mainly to three regions (residues 62-83, 95-121, and 
135-177)  in  the  first  two amino-terminal  extracellular  domains  of the  class  I 
molecule (3).  Structural analysis of HLA-A2 variants in the human (5) and H-2 
mutant  strains  of  mice  (6)  have  shown  that  determinants  defined  by  CTL 
recognition  reside in  the first two external domains, a  suggestion that  it is the 
polymorphism  of these  regions  that  is  important  for the  immune  function  of 
these molecules. 
An intriguing aspect of the polymorphism of the murine H-2 class I molecules 
is  the  apparent  lack  of shared  intralocus  determinants,  i.e.,  there  is  little  to 
indicate that  the products of the K alleles are structurally different from those 
of the  D alleles (1).  There  is some possibility that  this  may not be true for the 
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products  of HLA  loci.  Yang  et  ai.  (7)  and  Billing  and  Lucero  (8)  have  both 
reported monoclonai antibodies (mAb) specific for all or most HLA-B-encoded 
gene products. Here, we show that a recently described (9) mAb, 131, recognizes 
a determinant unique to HLA-A locus-encoded proteins. Taken together, these 
data  suggest that  shared  intralocus  determinants,  definable by mAb, do in fact 
exist in the human HLA system. 
Materials and  Methods 
Cell Lines.  Human cell lines were maintained at 37°C in RPMI-I640 supplemented 
with  10% fetal bovine serum (FBS),  25  mM Hepes, and 2 mM glutamine. All cell lines 
are B lymphoblastoid cell lines with the exception of Molt 4, a T  cell line, and K562, an 
erythroleukemia cell line. The HLA-A,B type for each cell line is provided in Table I. 
Mouse L cells transfected with human class I  genes were kindly provided by J. Barbosa 
(Harvard University, Cambridge, M A). The L cell transfectants were maintained at 37 °C 
in Dulbecco's a minimum essential medium supplemented with 10% FBS, 25 mM Hepes, 
and 2 mM glutamine. LJE1 has been transfected with the HLA-A2 and the human/32-m 
genes;  LJG3 with HLA-B7 and human ~2-m; LB.40.10  with HLA-B40; and LJCM has 
been transfected only with the human 132-m gene (10). 
Antibodies.  mAb  131  was produced in our lab and has been described before (9);  it 
reacts with a subset of class I proteins. W6/32 (11) recognizes a nonpolymorphic deter- 
minant shared by all HLA class I gene products,  mAb 4E, specific for all HLA-B gene 
products and HLA-A29, -A30, -A31, and -A32 (7),  was kindly provided by S.-Y.  Yang 
(Memorial Sloan-Kettering Cancer Center, New York); control antibody P3 was provided 
by M.  Hemler (Harvard University). Mouse mAb PA2.1  (12) and BB7.1  (13) recognize 
allospecific determinants found on  HLA-A2 and  HLA-B7 gene products,  respectively. 
mAb 187.1, a rat antibody specific for mouse ~ light chains, and which binds protein A, 
was grown from hybridoma cells obtained through the American Type Culture Collection, 
Rockville, MD. Rabbit antiserum raised against mouse F(ab) fragments was produced in 
our lab. 
Cell-surface  Binding Assays.  Radioimmunoassays (RIA) to test mAb binding  to cell- 
surface antigens  were carried out at 4°C  in phosphate buffered saline (PBS),  pH 7.4, 
containing  1%  FBS and  0.05%  NaN~  (henceforth  termed  PBS-FBS-Az).  Washed  cells 
were plated in 96-well U-bottom plates at 105 cells/100 ~l/well.  Antibodies were added 
(25/~l/well culture supernatants) and the plates were incubated for 1 h. After three washes 
5  1251  in PBS-FBS-Az, 10  cpm/25 #i/well of  I-labelled goat anti-mouse IgG,A,M was added, 
followed by another 1-h incubation. After five washes in PBS-FBS-Az, cells were harvested, 
and the number of counts bound was determined. In all cases, background radioactivity 
bound to cells in the absence of a primary mAb have been subtracted. 
Indirect immunofluorescence flow cytometry was carried out as described previously 
(9). Cells were examined with a FACS IV fluorescence-activated cell sorter analyzer. 
Protein  Radiolabelling and lmmunoprecipitation.  Cells (2-4  x  108 cells  in  2  ml) were 
biosynthetically labelled in  methionine-deficient  medium  (RPMI  1640  Met,  Gibco Se- 
lectamine Kit; Gibco, Grand Island, NY) supplemented with  15% dialyzed FBS, 25 mM 
Hepes, 2 mM glutamine, and 250 #Ci/ml p~S]metbionine (Amersham Corp., Arlington 
Heights, I L). After a  12-18-h incubation at 37 °C, radiolabelled cells were washed twice 
in  10  ml ice-cold Hank's balanced salt solution. The cell pellets were suspended in ice- 
cold lysis buffer (1 ml of 10 mM Tris, pH 7.0, containing  1% Nonidet P-40 (NP-40),  10 
mM iodoacetamide, and  1 mM phenylmethylsulfonylfluoride for 40 min after vigorous 
vortexing. The lysates were then centrifuged at  10,000 g for 10 min to remove cellular 
debris, and were dialyzed overnight against two changes of 40 mM NaCI in 10 mM Tris, 
pH 7.8. 
Cell-surface proteins were labelled with ~I  by the lactoperoxidase method (14).  2-3 × 
107 cells (>96% viable by Trypan Blue dye exclusion) were labelled, washed three times 
in  10 ml of PBS containing 2.1  gm KI per 100 ml, and lysed in  1 ml of 1% NP-40 in  10 
mM Tris, and treated as described above. 1804  AN  HLA-A  INTRALOCUS  DETERMINANT 
Before immunoprecipitation, 1 ml of lysates were incubated with two cycles of heat- 
inactivated, formalin-fixed Staphylococcus  aureus  (packed pellet from 250  ~1  of a  10% 
wt/vol suspension)  and 20 ul of normal rabbit serum to remove nonspecifically bound 
proteins. Precleared lysates were used immediately or stored at -70°C.  All steps  were 
carried out at 4°C. 
For immunoprecipitation, precleared lysates corresponding to  106 cells (250-500 #1) 
for 35S-labelled material, or 3-5 ×  10  6 cells (100 #1) for  25I-labelled lysates were added to 
equal volumes of wash buffer (50 mM Tris, pH 7.8, 150 mM NaCI, 5 mM EDTA, 0.1% 
Az,  0.5%  NP-40,  0.5%  deoxycholic acid,  10%  glycerol). Antibodies (2  ul  ascites  per 
sample)  were added, followed by an overnight incubation. For mAb  131,  rabbit anti- 
mouse F(ab) (25 #l) or 187.1  (10 ul ascites) was added to facilitate S.  aureus  binding. S. 
aureus  (100  ul  of a  10%  wt/vol suspension)  was added, followed by a  1-h incubation. 
Immune complexes were washed three times in 0.6 ml wash buffer. For isoelectric focusing 
(IEF), O'Farrell method (15) (see below), S.  aureus pellets were resuspended in 40 IA IEF 
sample buffer, heated to 60°C for 15 min, and centrifuged. For IEF by the method of 
Krangel et al. (16),  S.  aureus  pellets were resuspended in  I00 ~1 of Laemmli's sample 
buffer, boiled for 2 rain, and centrifuged. Supernatants containing class I proteins were 
carefully removed and analyzed as described below. 
Two-dimensional  IEF  Analysis.  Proteins  were  resolved according to  the  method of 
O'Farrell (15). Briefly, class I antigens in 20 IA IEF sample buffer were separated in the 
first dimension by IEF using 2% ampholines (one part pH 3.5-10, two parts pH 4-6, two 
parts pH 6.8). After equilibrating the gels for 45 rain, proteins were further resolved in 
a second dimension by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS- 
PAGE) using 12% polyacrylamide. 
Proteins were also resolved as described by Krangel et al. (16). Immunopurified class I 
antigens (50/A) were resolved by SDS-PAGE using 7.5% acrylamide according to Laemmli 
(17). Using dansylated alcohol dehydrogenase (41 kD) as a molecular marker, the portion 
of the gel corresponding to 40-45 kD was excised, equilibrated, and polymerized into the 
IEF gel containing 2% ampholines (one part pH 3.5-10, one part pH 4-6, one part pH 
6-8). Electrophoresis was carried out for 7 h at 1,000 V. 
After electrophoresis, gels were fixed, enhanced (New England Nuclear, Boston, MA), 
and dried. Radioactive bands were detected by fluorography at -70°C using Kodak XR- 
5 film. 
Results 
Previous sequential immunoprecipitation and preclearing studies have shown 
that  mAb  131,  made against the  human  natural  killer cell  line  3.3,  detects  a 
subpopulation  of class  1  molecules  detected  by  the  pan-HLA-reactive  mAb 
W6/32 (9). That mAb  131  detects only some of the class I proteins precipitated 
by W6/32 is further shown in Fig.  1.  Here,  125I-labelled JY (HLA-A2, B7) cell 
lysates  were  immunoprecipitated  with  a  panel  of  class  I-specific  mAb  and 
resolved on two-dimensional O'Farrell  gels (15).  The results show that W6/32 
reacts with both the HLA-A2 and HLA-B7 45  kD proteins (Fig.  1 A), whereas 
131  immunoprecipitates only the more basic HLA-A2 protein  (Fig.  1B).  mAb 
4E, which recognizes a  determinant shared by all HLA-B locus proteins as well 
as HLA-A29, -A30, -A31, and -A32 proteins (7), reacts only with the more acidic 
HLA-B7 protein (Fig.  1 D). The relative positions of the HLA-A2 and HLA-B7 
spots  were  confirmed  by  analysis  of proteins  immunoprecipitated  with  mAb 
PA2.1  (anti-HLA-A2) (Fig.  1 C) and BB7.1  (anti-HLA-B7) (Fig.  1E). 
NK3.3, the immunizing cell line, andJY share the HLA-B7 allele, but express 
different HLA-A alleles, thus raising the possibility that mAb 131 may be specific 
for a  number of different HLA-A locus-encoded gene products.  To  examine AN  HLA-A  INTRALOCUS  DETERMINANT  1805 
FIGURE  1.  O'Farrell two-dimensional analysis of class I  proteins immunoprecipitated with 
mAb W6/32,  131, PA2.1,  4E, and BBT.1. The first dimension is 1EF,  with the basic end of 
the gel to the right. The second dimension is SDS-PAGE. The  12 kD spot, corresponding to 
/3~-m, has been aligned in all five gels. At 45 kD, the more basic HLA-A2 and the more acidic 
HLA-B7 spots can be seen when using W6132 (A). Only the more basic spot corresponding to 
HLA-A2 is seen when immunoprecipitating with 131 (B) or the HLA-A2-specific mAb, PA2.1 
(C).  The more acidic spot, corresponding to HLA-B7, can be seen with the HLA-B-specific 
mAb, 4E (D), or the HLA-B7°specific mAb, BB7.1 (E). F
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 AN  HLA-A 1NTRALOCUS DETERMINANT 
TABLE  I 
Binding Profiles of mAb on Panel of Human Cell Lines as Assessed  by 
CeU-surface  RIA 
~SI-Goat anti-mouse Ig 
Cell line  HLA-A  HLA-B  bound (cpm) 
131  W6/32  P3 
Daudi  --  --  147  244  44 
K562  --  --  142  156  0 
Molt-4  1, 10  NT  934  2,542  14 
MICH  2, 32  27, 15  3,239  6,992  192 
JY  2  7  4,810  7,038  148 
IBW 4  3  35  3,647  4,455  66 
Herluff  2  12, 35  3,375  3,842  99 
THAL B  3,10  5,35  5,103  7,933  135 
IBW 9  33  14  2,187  3,840  98 
WT51  9  14  3,912  7,408  80 
23.1  2  27  3,150  4,438  0 
LB  2  40  1,891  3,133  0 
WT46  32  13  2,011  2,507  0 
AS  2,24  27  4,564  5,417  20 
Preiss  2  15  2,322  666  0 
WT49  2  17  4,673  4,862  30 
LBF  30  13  4,627  5,807  140 
Mann  29  12  3,679  4,324  0 
HOM-2  3  27  3,483  3,807  49 
1807 
this  possibility,  class  I  proteins  from a  number  of different [35S]methionine- 
labelled B  lymphoblastoid cell lines were immunoprecipitated with mAb  131, 
4E,  and  W6/32,  and  analyzed on  two-dimensional  IEF  gels  as  described by 
Krangel et al.  (16).  The results (Fig.  2) indicate that, for each of the different 
cell lines, the IEF banding profiles seen with  131  and 4E can be combined to 
produce the'W6/32 profile. Note also that mAb 131  and 4E, as expected, both 
react with HLA-A32 from MICH. From these data, we conclude that mAb 131 
reacts with all of the HLA-A proteins tested (HLA-A2, -A3, -A9, -A24, -A28, 
and -A32), but not with the HLA-B proteins (HLA-B7,-B14,-B27,  -B35, and 
-B40). 
Table  I  shows  the  cell-surface binding  profiles  of mAb  131  and  W6/32, 
determined by RIA, on a panel of 19 human cell lines displaying 11  different 
HLA-A  proteins  and  12  different  HLA-B  proteins.  As  expected,  131  and 
W6/32  do  not  bind  to  Daudi  and  K562;  neither  cell  line  expresses  class  I 
proteins. All other cell lines bind both of these antibodies. 
The specificity of mAb 131  for HLA-A2, and lack of reactivity with HLA-B7, 
-B40, and/~2-m is shown by FACS analysis of mouse L cell lines transfected with 
these genes (Fig.  3).  As expected, mAb W6/32,  131, and 4E bind to JY (A2  +, 
B7÷),  W6/32  and  131  bind to LJE1  (A2+),  W6/32 and 4E bind to LJG3  (B7 ÷) 
and LB.40.10 (B40+),  but not to LJCM (/~2-m). The bimodal peaks seen with the 
LB.40.10 line indicate a heterogeneous population of cells; subclones have arisen 
lacking expression of the transfected class  I B40 gene. Negative FACS staining 
by 131  on LJG3 and LB.40.10  rules out detectable low-affinity binding by this 
antibody to HLA-B7 and -B40. 1808  AN  HLA-A  INTRALOCUS  DETERMINANT 
JY(A2,BT)  J  LJ El(A2)  I  L JG3 (B7)  LB.40.10(B4.0)  I  LJCM(-) 
it  tl 
tt  fl 
f;  ii t  I  i 
0  t  2  3  4  0  1  2  3  4  0  J  2  3  4  0  !  2  3  4  0  !  2  3  4 
Log  Fluorescence  Intensity 
FIGURE  3.  Indirect immunofluorescence of JY and mouse L  cells transfected with human 
class I genes.  106 cells were incubated for 1 h at 4°C with the primary mAb (denoted on the 
left side of the figure). Cells were washed, incubated for another hour with a fluoresceinated 
goat anti-mouse Ig, washed again, and analyzed with a FACS IV. JY is typed as HLA-A2,B7. 
LJEI  has been transfected with the HLA-A2 and human/32-m genes; LJG3 with HLA-B7 and 
human B~-m; LB.40.10 with HLA-B40; LJCM has been transfected only with the human/3~- 
m  gene.  tago denotes negative controls; hatched lines indicate autofluorescence,  solid lines 
indicate staining with only the fluoresceinated second antibody. For W6/32,  131, and 4E, the 
solid lines indicate staining with those mAb; hatched lines corresponded to the tago control. 
The HLA genes expressed by the cell lines tested are given in parentheses at the top of the 
figure. 
Discussion 
The results presented above indicate that mAb 131  recognizes a determinant 
expressed on a  number of different HLA-A proteins,  mAb  131  is therefore a 
candidate for a pan-reactive HLA-A antibody, and to our knowledge, this is the 
first description of such an antibody. From IEF analysis, we have demonstrated 
that 131  reacts with HLA-A2, -A3, -A9, -A24, -A28, -A32, and -A33, and shows 
no apparent reactivity with HLA-B7, -B 14, -B27, -B35, and -B40 allelic products. 
FACS analysis on  mouse L  cells  transfected with HLA class  I  genes confirms 
reactivity with HLA-A2 and the absence of binding to HLA-B7 and -B40.  Ceil- 
surface binding assays with 19 different cell lines show that mAb 131  reacts with 
all HLA  ÷ cells tested. IEF studies are currently in progress with a larger panel 
of cells  to determine whether the determinant detected by mAb 131  is unique 
only for HLA-A proteins. 
Two HLA-B-specific mAb, 4E (7) (4E crossreacts with some HLA-A alleles), SPEAR  ET  AL.  1809 
and  4G  (8),  have  been  reported.  Cresswell  and  Ayres  (18)  produced  rabbit 
antisera against purified HLA-A2 and -B7/-B12 antigens that displayed reactivity 
with other HLA-A and  HLA-B alleles, respectively. These findings, along with 
our description of 131, provide serological evidence for the existence of some 
structural feature that distinguishes HLA-A and -B locus products. Evidence for 
such "A-ness" and "B-ness" is also supported at the molecular level. Arnot et al. 
(19) have recently described cDNA probes that  define shared  HLA intralocus 
sequences in  class  I  mRNA.  Whether  such  shared  intralocus  sequences corre- 
spond to epitopes detected by locus-specific mAb remains to be determined. 
The possibility of shared intralocus determinants  raises questions concerning 
the molecular nature of these epitopes and what biological function, if any, they 
may have. We are now attempting to biochemically characterize the epitope seen 
by 131. mAb  131  reacts with isolated class I  heavy chains in protein  blots, but 
only  under  nonreducing  conditions  (B.  Spear, J.  Kornbluth,  and  D.  Wilson, 
manuscript in preparation).  It therefore appears that the structural  integrity of 
the  epitope defined by mAb  131  on class  I  heavy chains  does not depend  on 
association with/32-m, but intact intrachain  disulfide bonds are necessary. 
It is clear that  HLA-A and -B locus proteins have similar functions of MHC- 
restricted antigen recognition; however, the conserved intralocus differences in 
structure  may also indicate that these molecules have some different functions. 
This possibility is supported by the recent findings (9, 20) that mAb 131  and 4E 
have different effects on the lyric activity and interleukin  2-dependent prolifer- 
ation of some human NK clones. If these findings can be extended, it will become 
an  important  issue  to  identify  the  structural  features  of HLA-A and  -B locus 
proteins that correlate with their differences in function. 
Summary 
We describe here a  monoclonal antibody,  131, which appears to recognize a 
determinant  shared by HLA-A locus-encoded gene products.  Isoelectric focus- 
ing analysis  demonstrates  that  131  reacts  with  the  products  of at  least  seven 
different  HLA-A  alleles  but  none  of the  five  HLA-B allelic  products  tested. 
Together  with  evidence provided  by other  studies,  this  finding  indicates  the 
existence  of A-unique  and  B-unique  determinants,  which  may  have  different 
biological  functions.  Monoclonal  antibody  probes,  such  as  the  one  described 
here, specific for shared intralocus determinants,  may be valuable for assessing 
these possible functional differences. 
We thank  S. Young Yang  for providing mAb 4E, J.  Barbosa  for supplying  transfected 
mouse L cells, and A. Pickard for performing FACS analysis. 
Received for publication 1 August 1985. 
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